Strengths and limitations of the EULAR definition for difficult-to-treat rheumatoid arthritis

The management of rheumatoid arthritis (RA) has significantly improved, but a substantial number of patients still experience persistent disease activity, leading to the concept of 'difficult-to-treat RA' (D2T RA). The European Alliance of Associations for Rheumatology (EULAR) has provided a pivotal definition for D2T RA to unify clinical approaches and research methods. This definition frames D2T RA as an umbrella term for a diverse group of patients with management challenges stemming from various factors, including biological resistance, patient experience, and clinical complexities. This framework is invaluable for a previously ill-defined population, but its real-life application highlights areas for ongoing consideration and potential refinement. Here, we discuss some of the strengths and limitations of the EULAR definition for D2T RA.

Authors

Institutions

Publication Details

Journal
RMD Open
Published
2025-10-01
DOI
https://doi.org/10.1136/rmdopen-2025-006271
Citations
2
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
3.34

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Strengths and limitations of the EULAR definition for difficult-to-treat rheumatoid arthritis

Maya H Buch, György Nagy
2 citations
RMD Open
Rheumatoid Arthritis Research and Therapies
3.34
article

Strengths and limitations of the EULAR definition for difficult-to-treat rheumatoid arthritis

Maya H Buch, György Nagy
article en
2 citations

Abstract

The management of rheumatoid arthritis (RA) has significantly improved, but a substantial number of patients still experience persistent disease activity, leading to the concept of 'difficult-to-treat RA' (D2T RA). The European Alliance of Associations for Rheumatology (EULAR) has provided a pivotal definition for D2T RA to unify clinical approaches and research methods. This definition frames D2T RA as an umbrella term for a diverse group of patients with management challenges stemming from various factors, including biological resistance, patient experience, and clinical complexities. This framework is invaluable for a previously ill-defined population, but its real-life application highlights areas for ongoing consideration and potential refinement. Here, we discuss some of the strengths and limitations of the EULAR definition for D2T RA.

RMD OpenVol. 11(4)
Semmelweis University (HU), Manchester Academic Health Science Centre (GB), NIHR Oxford Musculoskeletal Biomedical Research Centre (GB), Manchester University NHS Foundation Trust (GB), NIHR Manchester Biomedical Research Centre (GB)
Eli Lilly and Company, Pfizer, AstraZeneca, Gilead Sciences, National Institute for Health and Care Research, Semmelweis Egyetem
Openalex Percentile: Top 7%
Rheumatoid Arthritis Research and Therapies
3.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Strengths and limitations of the EULAR definition for difficult-to-treat rheumatoid arthritis — Maya H Buch, György Nagy · RMD Open (2025) | TGRS Research Map | TGRS